ABLE, in collaboration with Choose New Jersey successfully concluded the webinar on the Institute for Life Science Entrepreneurship (ILSE) & the New Jersey-India Biotech Corridor. The webinar highlighted New Jersey’s thriving life sciences ecosystem, showcasing its cutting-edge infrastructure, funding opportunities, and collaborative business environment, making it an ideal destination for Indian biotech companies looking to expand into the U.S. market.

The webinar the event highlighted the strengthening U.S.-India biotech ties, with India contributing 20% of biosimilars and 33% of generics globally. New Jersey's world-class R&D facilities were recognized as a major driver of biotech innovation, offering state-backed grants and incentives to help life science entrepreneurs scale their operations. The state’s top-tier universities provide a highly skilled STEM workforce, further supporting industry growth. Additionally, Indian biotech firms are expanding rapidly in New Jersey, leveraging technology transfer and commercial support to enhance their global footprint.

Watch the full recording here: https://www.youtube.com/watch?v=qA2Xp0CYWxA